Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
25.33
-0.98 (-3.72%)
At close: Jul 6, 2026, 4:00 PM EDT
25.82
+0.49 (1.93%)
After-hours: Jul 6, 2026, 6:25 PM EDT
Zymeworks Employees
Zymeworks had 243 employees as of March 31, 2026. The number of employees decreased by 56 or -18.73% compared to the same quarter last year.
Employees
243
Change
-56
Growth
-18.73%
Revenue / Employee
$334,416
Profits / Employee
-$422,453
Market Cap
1.85B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Nuvation Bio | 307 |
| Syndax Pharmaceuticals | 298 |
| UroGen Pharma | 298 |
| Absci | 140 |
| Bicara Therapeutics | 103 |
| AtaiBeckley | 99 |
| Rapport Therapeutics | 84 |
ZYME News
- 6 days ago - Zymeworks price target raised to $37 from $34 at Wells Fargo - TheFly
- 6 days ago - Zymeworks price target raised to $37 from $35 at Citi - TheFly
- 7 days ago - Zymeworks Transcript: M&A announcement - Transcripts
- 7 days ago - Zymeworks Press release: M&A announcement - Filings
- 7 days ago - Zymeworks Slides: M&A announcement - Filings
- 7 days ago - M&A News: Biotech Group Zymeworks Buys Lung Disease-Fighting Peer Theravance for $1B - TipRanks
- 7 days ago - Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash - TheFly
- 7 days ago - Zymeworks strikes $929 million deal for Theravance Biopharma - Reuters